| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/15/2011 | US7906491 Compounds for modulating the activity of exchange proteins directly activated by cAMP (Epacs) |
| 03/15/2011 | US7906141 Sustained-release, oral pharmaceutical forms of formulation |
| 03/15/2011 | CA2613030C Agent for the treatment of herpes virus-derived pain |
| 03/15/2011 | CA2566331C Oral delivery system |
| 03/15/2011 | CA2480708C Method and dietary composition for improving fat digestibility |
| 03/15/2011 | CA2477774C Indolylmaleimide derivatives |
| 03/15/2011 | CA2471814C Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient |
| 03/15/2011 | CA2468311C Benzothiazole derivatives |
| 03/15/2011 | CA2463681C Ready-to-use paracetamol injection solutions containing propylene glycol as the only cosolvent |
| 03/15/2011 | CA2462228C 4-(c2-6alkoxy)-substituted chalcones as therapeutic agents |
| 03/15/2011 | CA2443235C Pharmaceutical compositions comprising ascomycin |
| 03/15/2011 | CA2433806C Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 03/15/2011 | CA2431160C Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
| 03/15/2011 | CA2412776C Compositions controlling release ph range and/or speed |
| 03/15/2011 | CA2406008C Composition exhibiting enhanced formulation stability and delivery of topical active ingredients |
| 03/15/2011 | CA2404196C Medical emulsion for lubrication and delivery of drugs |
| 03/15/2011 | CA2397366C Methanocarba cycloalkyl nucleoside analogues |
| 03/15/2011 | CA2394809C Benzazole derivatives and their use as jnk modulators |
| 03/15/2011 | CA2383284C Use of ribose to prevent cramping and soreness in muscles |
| 03/15/2011 | CA2379575C Pharmaceutically active sulfonamide derivatives |
| 03/15/2011 | CA2373653C New use of compounds as antibacterial agents |
| 03/15/2011 | CA2360415C Benzimidazole vascular damaging agents |
| 03/15/2011 | CA2289119C Methods for treating inflammation and inflammatory diseases using padprt inhibitors |
| 03/10/2011 | WO2011029001A1 Compounds as tyrosine kinase modulators |
| 03/10/2011 | WO2011028995A1 Compounds as tyrosine kinase modulators |
| 03/10/2011 | WO2011028673A2 A composition for delaying cellular senescence |
| 03/10/2011 | WO2011028651A1 Inhibitors of human 15-lipoxygenase-1 |
| 03/10/2011 | WO2011028542A2 Methods of treating pain associated with complex regional pain syndrome |
| 03/10/2011 | WO2011027119A1 Combination medicament |
| 03/10/2011 | WO2011027009A1 Pharmaceutical composition comprising ibuprofen, tramadol and a basic amino acid, preparation method thereof and use of same |
| 03/10/2011 | WO2011026781A1 Novel multifunctional peptidase inhibitors, especially for medical use |
| 03/10/2011 | WO2011026362A1 Use of cobrotoxin for manufacturing a medicament for the treatment of arthritis |
| 03/10/2011 | WO2011026267A1 Antiphlogistic, antioncotic and analgesic chinese herbal composition,preparative method and usage thereof |
| 03/10/2011 | WO2011008666A3 3-phenoxymethylpyrrolidine compounds |
| 03/10/2011 | WO2010135527A9 Elastin for soft tissue augmentation |
| 03/10/2011 | US20110061114 Novel pro258 gene disruptions, and methods relating thereto |
| 03/10/2011 | US20110060290 Stabilized protein compositions |
| 03/10/2011 | US20110060053 Crystalline Modifications of 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol |
| 03/10/2011 | US20110060049 Derivatives of n-(arylamino) sulfonamides including polymorphs as inhibitors of mek as well as compositions, methods of use and methods for preparing the same |
| 03/10/2011 | US20110060025 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor |
| 03/10/2011 | US20110060024 Modulators of ATP-Binding Cassette Transporters |
| 03/10/2011 | US20110060017 Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 03/10/2011 | US20110060012 4-[3-(aryloxy)benzylidene]-3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors |
| 03/10/2011 | US20110060010 Salts of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)piperidine-2,6-dione and derivatives thereof, or polymorphs of salts, process for preparing same and use thereof |
| 03/10/2011 | US20110060006 Functionally Selective Alpha2C Adrenoreceptor Agonists |
| 03/10/2011 | US20110060005 Treatment of mitochondrial disorders using a farnesyl transferase inhibitor |
| 03/10/2011 | US20110060004 Imidazo-Pyridine Derivatives as Activin-Like Receptor Kinase (ALK4 or ALK5) Inhibitors |
| 03/10/2011 | US20110060001 Thienopyridone derivatives as amp- activated protein kinase (ampk) activators |
| 03/10/2011 | US20110059999 Hydroxymethylcyclohexylamines |
| 03/10/2011 | US20110059984 Heterocycles useful as modulators of ion channels |
| 03/10/2011 | US20110059983 Use of substituted oxindole derivatives for the treatment and prophylaxis of pain |
| 03/10/2011 | US20110059979 Piperidine/Cyclohexane Carboxamide Derivatives For Use as Vanilloid Receptor Modulators |
| 03/10/2011 | US20110059970 4-phenyl-1,3-thiazoles and 4-phenyl-1,3-oxazoles derivatives as cannabinoid receptor ligands |
| 03/10/2011 | US20110059966 Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders |
| 03/10/2011 | US20110059965 Bicyclic derivatives as modulators of ion channels |
| 03/10/2011 | US20110059964 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 03/10/2011 | US20110059963 Compounds and methods for kinase modulation, and indications therefor |
| 03/10/2011 | US20110059959 Novel multicyclic compounds and the use thereof |
| 03/10/2011 | US20110059957 Benzene or thiophene derivative and use thereof as vap-1 inhibitor |
| 03/10/2011 | US20110059956 Therapeutic agent for pain |
| 03/10/2011 | US20110059952 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
| 03/10/2011 | US20110059951 HETEROCYCLIC DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 03/10/2011 | US20110059944 Certain Substituted Amides, Method of Making, and Method of Use Thereof |
| 03/10/2011 | US20110059938 New chemical compounds |
| 03/10/2011 | US20110059935 Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTS |
| 03/10/2011 | US20110059934 Compounds and compositions useful for the treatment of parasitic diseases |
| 03/10/2011 | US20110059931 Biphenyl compounds useful as muscarinic receptor antagonists |
| 03/10/2011 | US20110059922 Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers |
| 03/10/2011 | US20110059919 Antiviral composition comprising a sulfated polysaccharide |
| 03/10/2011 | US20110059907 Chiral Complexes of Ascorbic Acid with Natural Antioxidant and Anti-Inflammatory Ketones Including Aloe, Citrus, Ginger, and Mango for Skin and Hair Care |
| 03/10/2011 | US20110059889 PEPTIDES THAT BLOCK THE BINDING OF IgG TO FcRn |
| 03/10/2011 | US20110059885 Treatment of diseases and conditions mediated by eicosanoids |
| 03/10/2011 | US20110059190 Cistus extract containing enriched secondary plant ingredients |
| 03/10/2011 | US20110059171 Oral galenic formulation including ketorolac and b-complex vitamins, in which vitamin b6 is in an outer layer separated from the rest of the active principles |
| 03/10/2011 | US20110059153 Use of anti-cytokine agents for treating carpal and tarsal tunnel syndrome |
| 03/10/2011 | US20110059139 Method for loading a molecule into a porous substrate |
| 03/10/2011 | US20110059136 Methods and Compositions for Treating Inflammatory Bowel Disease |
| 03/10/2011 | US20110059118 Inhibitors of jak |
| 03/10/2011 | US20110059117 Liquid Compositions Capable of Foaming and Including Active Agents, and Methods for Making or Developing Same |
| 03/10/2011 | US20110059107 Antikine antibodies that bind to multiple cc chemokines |
| 03/10/2011 | US20110059105 Tie complex binding proteins |
| 03/10/2011 | US20110059095 High affinity human antibodies to human protease-activated receptor-2 |
| 03/10/2011 | US20110059084 Agent for treating disease |
| 03/10/2011 | US20110059083 Agent for treating disease |
| 03/10/2011 | US20110059082 Agent for treating disease |
| 03/10/2011 | US20110059079 Antibody Coformulations |
| 03/10/2011 | US20110059067 Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides |
| 03/10/2011 | US20110059058 Strain of Lactobacillus Rhamnosus |
| 03/10/2011 | US20110059019 Novel aryl piperazine derivatives useful as modulators of dopamine and serotonin receptors |
| 03/10/2011 | US20110059012 Identification of cd8+ t cells that are cd161hi and/or il18r (alpha) hi and have rapid drug efflux capacity |
| 03/10/2011 | US20110059010 Dual phase drug release system |
| 03/10/2011 | CA2809198A1 Combination medicament |
| 03/10/2011 | CA2773176A1 Treatment of diseases caused by bacterial exotoxins |
| 03/10/2011 | CA2772975A1 Novel multifunctional peptidase inhibitors, especially for medical use |
| 03/10/2011 | CA2772718A1 Compounds as tyrosine kinase modulators |
| 03/10/2011 | CA2772625A1 Compounds as tyrosine kinase modulators |
| 03/09/2011 | EP2292771A2 Sense mRNA therapy |
| 03/09/2011 | EP2292770A2 Methods and means for producing proteins with predetermined post-translational modifications |
| 03/09/2011 | EP2292734A1 Hematopoietic cells from human embryonic stem cells |
| 03/09/2011 | EP2292630A1 O2-substituted 1- (2-carboxylato)pyrrolidin-1-yl diazen-1-ium-1,2-diolates |